Experiment 66946

Details

PropertyValue
Pharmacology
Administration routeORAL
OrganismVaccinium myrtillus (ERICACEAE)
CitationBRAVETTI,O: FRABONI,E: MACCOLINI,E:. (1989). PREVENTIVE MEDICAL TREATMENT OF SENILE CATARACT WITH VITAMIN E AND VACCINIUM MYRTILLUS ANTHOCIANOSIDES: CLINICAL EVALUATION.. 115()
Amount utilized
Compound isolated
DiseaseFIFTY OUTPATIENTS, 21 MEN AND 29 WOMEN SUFFERING FROM MILD SENILE CORTICAL CATARACT UNDERGONE THERAPY WITH VITAMIN E + VACCINIUM MYRTILLUS ANTHOCIASONSIDE (FAR-1: 2 TAB. B.I.D.) FOR 4 MONTHS. THE STUDY WAS A RANDOMIZED DOUBLE-BLIND PLACEBO- CONTROLLED TRIAL. FAR-1 WAS ABLE TO STOP THE LENS OPACITY PROGRESS IN THE 97% OF THE EYES. NO UNTOWARDS EFFECTS OR ADVERSE-DRUG REACTION WERE RECORDED.
Number1
Qualitative resultACTIVE
AnimalHUMAN ADULT
Dose expressionDOSE
ExtractANTHOCYANOSIDE FRACTION
GenderGIVEN TO BOTH SEXES